市场调查报告书
商品编码
1468513
2024-2032 年按产品类型(影像设备、显微镜、免疫分析、分子诊断等)、最终用途(医院、诊断实验室等)和地区分類的皮肤科诊断设备市场报告Dermatology Diagnostic Devices Market Report by Product Type (Imaging Devices, Microscopes, Immunoassays, Molecular Diagnostics, and Others), End Use (Hospitals, Diagnostic Labs, and Others), and Region 2024-2032 |
2023年,全球IMARC Group诊断设备市场规模达到1,61亿美元。皮肤病的盛行率不断上升、对非侵入性手术方法的需求不断增加以及专科诊所和医院数量的增加是推动市场的一些关键因素。
技术进步推动市场成长
各种技术进步是导致皮肤病诊断设备需求不断增长的主要驱动力之一。人们越来越关注提高皮肤科设备检测机制的准确性和灵敏度,这正在加强市场的成长。此外,用于检测非恶性黑色素瘤早期迹象的数位皮肤镜的推出正在对市场产生积极影响。除此之外,市场上还有各种基于行动装置的皮肤科诊断技术,可以轻鬆筛检和追踪各种皮肤状况。此外,人工智慧(AI)在早期皮肤癌皮肤病诊断设备中的整合正在推动市场成长。
报告涵盖了市场结构、主要参与者的市场份额、参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外,也提供了所有主要公司的详细资料。市场结构集中,规模较小,占大部分市场份额。由于资本投资高和退出障碍高,皮肤科诊断设备产业的新进者数量适中。
什么是皮肤科诊断设备?
皮肤病诊断设备包括影像、显微镜、免疫测定和分子诊断设备。根据疾病类型,它们有不同的尺寸、形状和附加功能。它们涉及各种技术,例如 X 射线和电脑断层扫描 (CT) 扫描来观察和诊断皮肤疾病。它们提高了准确性,有助于提高治疗效果,同时减少復发的机会。它们用于对皮肤进行目视检查和显微镜观察,这有助于识别疾病并指定治疗计划。它们也用于治疗个体中的痤疮、伤口、皮肤肿瘤、疥疮、脱髮、真菌感染、色素沉着、皮肤癌、皮肤损伤、头皮问题和黑色素瘤。因此,皮肤科诊断设备被应用于全球的医院、诊断实验室和专业皮肤护理中心。
COVID-19大流行的爆发给皮肤科诊断设备行业带来了问题,并给许多国家带来了前所未有的挑战。皮肤科诊断设备是必需产品,其生产设施在封锁期间仍在继续运作。疫情初期,由于原料供应链中断、劳动力短缺和库存不足,皮肤科诊断设备的製造受到影响。此外,由于封锁和实施社交距离规范,各製造商纷纷缩减产能或暂停生产。由于全球大流行危机,皮肤科诊断设备的原料进口减少。除此之外,由于医院和诊所的非紧急就诊急剧减少,大流行期间对皮肤科诊断设备的需求也受到了阻碍。世界各地的人们对线上咨询的偏好日益增加。此外,非必要的手术被推迟,影响了对皮肤科诊断设备的需求。此外,由于冠状病毒在全球范围内的广泛传播,主要参与者的各种策略计划和项目已被推迟或取消。
目前,由于脱髮、牛皮癣和湿疹等皮肤病的盛行率不断上升,对皮肤科诊断设备的需求不断增长,这是支持市场成长的关键因素之一。除此之外,用于治疗个人皮肤色素沉着、过敏反应以及真菌和细菌感染的皮肤科手术在化妆品行业中越来越受欢迎,这提供了积极的市场前景。此外,世界各地的医院和诊所对较小且易于使用的设备的需求也在增加。再加上越来越多地利用皮肤病诊断设备来检测个别疾病的早期迹象,正在推动市场的成长。除此之外,全球个人对非侵入性手术方法不断增长的需求为行业投资者提供了利润丰厚的成长机会。此外,全球越来越多的专科诊所和医院正在对市场产生积极影响。此外,基于行动技术的皮肤病诊断技术的使用不断增加,这些技术可以追踪和筛检皮肤状况,这也促进了市场的成长。此外,主要参与者正在推出执行影像技术的设备,例如皮肤镜检查和光学相干断层扫描,这正在加强市场成长。
The global dermatology diagnostic devices market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 34.4 Billion by 2032, exhibiting a growth rate (CAGR) of 8.6% during 2024-2032. The growing prevalence of skin disorders, increasing demand for non-invasive surgical methods, and rising number of specialty clinics and hospitals represent some of the key factors driving the market.
Technological Advancements Propelling Market Growth
Various technological advancements represent one of the primary drivers resulting in the increasing demand for dermatology diagnostic devices. The rising focus on enhancing the accuracy and sensitivity of the detection mechanism in dermatology devices is strengthening the growth of the market. In addition, the introduction of a digital dermatoscope for detecting the early signs of non-malignant melanomas is positively influencing the market. In addition to this, various mobile-based technologies for dermatology diagnosis are available in the market that easily screen and track various skin conditions. Also, the integration of artificial intelligence (AI) in dermatology diagnostic devices for early skin cancer is impelling the market growth.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is concentrated in nature with few large-scale accounting for the majority of the market share. The volume of new entrants is moderate in the dermatology diagnostic devices industry due to the high capital investments and exit barriers.
What are Dermatology Diagnostic Devices?
Dermatology diagnostic devices comprise imaging, microscopes, immunoassays, and molecular diagnostics devices. They are widely available in different sizes, shapes, and additional features as per the disease type. They involve various technologies, such as X-rays and computed tomography (CT) scans to observe and diagnose skin ailments. They offer enhanced accuracy and aid in improving treatment efficacy while reducing the chances of reoccurrences. They are used to perform a visual examination and microscopic observation of the skin, which assists in identifying the disease and specifying a treatment plan. They are also utilized to treat acne, wounds, skin tumors, scabies, hair loss, fungal infection, pigmentation, skin cancer, skin lesions, scalp problems, and melanoma among individuals. As a result, dermatology diagnostics devices are employed in hospitals, diagnostic labs, and specialty skin care centers across the globe.
The COVID-19 pandemic outbreak has caused a problem for the dermatology diagnostic devices industry and imposed unprecedented challenges on numerous countries. Dermatology diagnostic devices are essential products, and their production facilities were continued during the lockdown period. The manufacturing of dermatology diagnostic devices has been affected in the initial period of the pandemic due to supply chain disruptions from raw materials, labor shortages, and low stocks. In addition, due to the lockdown and imposition of social distancing norms, various manufacturers have downscaled capacity or paused their production. Import of raw materials for dermatology diagnostic devices has reduced due to the global pandemic crisis. Besides this, the demand for dermatology diagnostics devices has been hampered during the pandemic due to a sharp reduction in non-emergency visits to hospitals and clinics. The rising preference for online consultations has been observed among individuals around the world. Moreover, non-essential surgeries have been postponed, impacting the demand for dermatology diagnostics devices. Furthermore, various strategic plans and projects of the key players have been postponed or canceled due to the widespread coronavirus across the globe.
At present, the rising demand for dermatology diagnostic devices due to the increasing prevalence of skin disorders, such as hair fall, psoriasis, and eczema, among the masses represents one of the key factors supporting the growth of the market. Besides this, the growing popularity of dermatology procedures in the cosmetic industry to treat skin pigmentations, allergic reactions, and fungal and bacterial infections among individuals is offering a positive market outlook. Additionally, there is a rise in the need for smaller and easy-to-use devices in hospitals and clinics around the world. This, coupled with the increasing utilization of dermatology diagnostic devices to detect early signs of diseases among individuals, is propelling the growth of the market. Apart from this, the rising demand for non-invasive surgical methods among individuals worldwide is offering lucrative growth opportunities to industry investors. Moreover, the increasing number of specialty clinics and hospitals across the globe is positively influencing the market. In addition, the rising utilization of mobile-based technologies for dermatology diagnosis that can track and screen skin conditions is contributing to the growth of the market. Furthermore, key players are introducing devices that perform imaging techniques, such as dermatoscopy and optical coherence tomography, which is strengthening the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global dermatology diagnostic devices market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on product type and end-use.
Imaging Devices
Microscopes
Immunoassays
Molecular Diagnostics
Others
The report has provided a detailed breakup and analysis of the dermatology diagnostic devices market based on the product type. This includes imaging devices, microscopes, immunoassays, molecular diagnostics, and others. According to the report, imaging devices represented the largest segment as they assist dermatologists in detecting skin diseases at an early phase and implementing appropriate medication and treatment. In addition, the wide availability of imaging devices that are used for dermatological examinations, such as point-and-shoot cameras, OCT and quantitative thermographic imaging (QTI), interchangeable lens system cameras and smartphone/tablet attachments, is propelling the market growth.
Hospitals
Diagnostic Labs
Others
A detailed breakup and analysis of the dermatology diagnostic devices market based on the end use has also been provided in the report. This includes hospitals, diagnostic labs, and others. According to the report, hospitals accounted for the largest market share as dermatology is an essential healthcare service provided under ambulatory care services of a hospital and dermatologists offer treatment services and consultations to patients. In addition, the wide availability of well-equipped dermatology departments and specialists in hospitals due to the rising number of patients requiring surgical, cosmetic, and aesthetic procedures.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America was the largest market for dermatology diagnostic devices. Some of the factors driving the North America dermatology diagnostic devices market included the rising prevalence of chronic skin disorders, such as psoriasis and melanoma among individuals. In addition, the increasing demand for accurate diagnosis due to poor survival rate of late diagnosis for melanoma and the growing awareness about the availability of non-invasive aesthetic procedures among individuals are bolstering the market growth in the region.
Abbott Diagnostics
Strata Skin Sciences
Michelson Diagnostics
Heine Optotechnik
Roche Diagnostics
Welch Allyn
Carl Zeiss Meditec
Nikon Corporation
Leica Microsystems GmbH
MELA Sciences, Inc.
GE Healthcare Ltd.
Bruker Corporation
Philips Healthcare
Siemens Healthcare Diagnostics Inc.
Toshiba Medical Systems Corporation
Photomedex, Inc.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.